RemeGen (9995) Schedules Board Meeting on October 30, 2025 to Review Unaudited Third Quarterly Results

Bulletin Express

Oct 17

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited note in the announcement that they accept no liability for its contents nor for any loss arising from reliance on it.

RemeGen Co., Ltd.* (Stock Code: 9995) has announced that its board of directors will convene a meeting on Thursday, October 30, 2025. The session will consider and approve the company’s unaudited results for the nine months ended September 30, 2025, along with other matters deemed necessary. The announcement was dated October 17, 2025, from Yantai, The People’s Republic of China.

The board is chaired by Mr. Wang Weidong (also an executive director). Executive directors include Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Lin Jian, and Mr. Wen Qingkai. Non-executive directors comprise Dr. Wang Liqiang and Dr. Su Xiaodi. Independent non-executive directors are Mr. Hao Xianjing, Mr. Chen Yunjin, and Mr. Huang Guobin.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1162013982"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1162013982\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1162013982?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-17 16:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162013982","market":"hk","top_or_hot":-1,"title":"RemeGen (9995) Schedules Board Meeting on October 30, 2025 to Review Unaudited Third Quarterly Results","media":"Bulletin Express","content":"<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited note in the announcement that they accept no liability for its contents nor for any loss arising from reliance on it.</p>\n<p>RemeGen Co., Ltd.* (Stock Code: 9995) has announced that its board of directors will convene a meeting on Thursday, October 30, 2025. The session will consider and approve the company’s unaudited results for the nine months ended September 30, 2025, along with other matters deemed necessary. The announcement was dated October 17, 2025, from Yantai, The People’s Republic of China.</p>\n<p>The board is chaired by Mr. Wang Weidong (also an executive director). Executive directors include Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Lin Jian, and Mr. Wen Qingkai. Non-executive directors comprise Dr. Wang Liqiang and Dr. Su Xiaodi. Independent non-executive directors are Mr. Hao Xianjing, Mr. Chen Yunjin, and Mr. Huang Guobin.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RemeGen (9995) Schedules Board Meeting on October 30, 2025 to Review Unaudited Third Quarterly Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRemeGen (9995) Schedules Board Meeting on October 30, 2025 to Review Unaudited Third Quarterly Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-10-17 16:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited note in the announcement that they accept no liability for its contents nor for any loss arising from reliance on it.</p>\n<p>RemeGen Co., Ltd.* (Stock Code: 9995) has announced that its board of directors will convene a meeting on Thursday, October 30, 2025. The session will consider and approve the company’s unaudited results for the nine months ended September 30, 2025, along with other matters deemed necessary. The announcement was dated October 17, 2025, from Yantai, The People’s Republic of China.</p>\n<p>The board is chaired by Mr. Wang Weidong (also an executive director). Executive directors include Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Lin Jian, and Mr. Wen Qingkai. Non-executive directors comprise Dr. Wang Liqiang and Dr. Su Xiaodi. Independent non-executive directors are Mr. Hao Xianjing, Mr. Chen Yunjin, and Mr. Huang Guobin.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09995","symbol_name":"荣昌生物","start_time":0,"source_url":"","article_id":"1162013982","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162013982","pubTimestamp":1760690870,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited note in the announcement that they accept no liability for its contents nor for any loss arising from reliance on...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09995":"荣昌生物"},"translate_title":"RemeGen(9995)定于2025年10月30日召开董事会，审查未经审计的第三季度业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09995":1},"content_text":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited note in the announcement that they accept no liability for its contents nor for any loss arising from reliance on it.\nRemeGen Co., Ltd.* (Stock Code: 9995) has announced that its board of directors will convene a meeting on Thursday, October 30, 2025. The session will consider and approve the company’s unaudited results for the nine months ended September 30, 2025, along with other matters deemed necessary. The announcement was dated October 17, 2025, from Yantai, The People’s Republic of China.\nThe board is chaired by Mr. Wang Weidong (also an executive director). Executive directors include Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Lin Jian, and Mr. Wen Qingkai. Non-executive directors comprise Dr. Wang Liqiang and Dr. Su Xiaodi. Independent non-executive directors are Mr. Hao Xianjing, Mr. Chen Yunjin, and Mr. Huang Guobin.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}